Drugs / Gluma
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial | ||||||
| — | NCT04512625 | Nov 2019 → Jan 2020 | dentin sensitivity | University of Jazan | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT04819867 Comparator | Dec 2018 → Mar 2019 | dentin sensitivity | Dow University of Health Sciences | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gluma | “The main aims and objectives of the present study were to evaluate and compare the effectiveness of three commercially available desensitizing agents: Gluma (Hareus Kulzer),...” NCT04512625 ↗ |
| Known as | Gluma desensitizer | “Group GL (Gluma desensitizer)” NCT04512625 ↗ |
| Modality | Other / unclassified | “Gluma is a desensitizer agent” NCT04819867 ↗ |
| Route | Topical | “Gluma desensitizer was applied according to the manufacturer's instructions.” NCT04819867 ↗ |